Rehabtronics is a medical device company based in Vancouver, BC. It developed Prelivia, described as the world's first neuroscience-based technology to protect patients against deadly pressure injuries. The company is focused on commercializing Prelivia to reduce the incidence of pressure injuries in patients. In November 2021 Rehabtronics announced an oversubscribed $1.6M funding round to support commercialization. The round was led by North Spring Capital.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

Nov 2021